FC
PROK icon

Finepoint Capital’s ProKidney PROK Stock Holding History

Finepoint Capital’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-980,000
Closed -$9.7M – 64
2021
Q4 		$9.7M Hold
980,000
– – 2.49% 18
2021
Q3 		$9.6M Buy
980,000
+123,402
+14% +$1.22M 1.64% 35
2021
Q2 		$8.66M Buy
+856,598
New +$8.66M 1.62% 31

Other funds holding PROK

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $200M AUM 23.6% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Finepoint Capital's PROK Position: Q1 2022 in Review

Finepoint Capital sold out of ProKidney (PROK) in Q1 2022, closing a stake of 980,000 shares — an estimated $9.7M sold.

Finepoint Capital first reported a position in PROK in Q2 2021 and held it in 3 quarters. The position peaked at $9.7M in Q4 2021. 80 funds tracked by Wall St. Rank hold PROK as of Q1 2022.

  • Finepoint Capital reported no remaining ProKidney position as of Q1 2022 after selling out during the quarter.
  • Finepoint Capital sold 980,000 ProKidney shares in Q1 2022, an estimated $9.7M.
  • Finepoint Capital first reported a position in ProKidney in Q2 2021 and held it in 3 quarters.
  • Finepoint Capital's ProKidney position peaked at $9.7M in Q4 2021.
  • 80 funds tracked by Wall St. Rank held ProKidney as of Q1 2022.

Based on Finepoint Capital's 13F filing for Q1 2022, filed 13 May 2022.